Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Paragon 28

Explore full profile

Forefoot, midfoot and hindfoot plates, screws, staples and allograft bone systems for use in foot and ankle surgery

Englewood, United StatesFounded 2010Health Tech & Medtech
Valuation $1.17B Market cap · 2025
Revenue $256M Latest reported FY
Total funding $0–10M Disclosed equity funding

About Paragon 28

Paragon 28, Inc. is a medical device company focused on advancing the science of foot and ankle surgery. The company designs, develops, and distributes a comprehensive range of products including specialized plating systems, patient-specific implants, and biologics. Paragon 28 serves orthopedic surgeons and healthcare providers who specialize in foot and ankle procedures. Operating in the medical device market, the company leverages a business model that combines innovation with quality, ensuring that their products meet the highest standards of efficacy and safety. Revenue is generated through the sale of their proprietary surgical systems and implants, which are designed to improve patient outcomes and streamline surgical procedures. Key products include the Ankle Fracture Plating System, Hindfoot TTC TC System, and the Patient Specific Titanium Talus Spacer, which has received FDA approval. Paragon 28 is committed to research and development, continuously working to introduce new solutions that address the evolving needs of foot and ankle surgery.

Source: Dealroom company data

At a glance

Founded
2010
Headquarters
Englewood, United States
Listing
IPO 2021
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Paragon 28.

See all news

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Piper Jaffray Private Capital Group
  • MVM Life Science Partners
  • Piper Sandler

Series B and later1 investor entered at this stage

  • Ares Management
Employees mapped 755 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 21 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
11 countries with
team presence
🇺🇸 United States86.2%
🇿🇦 South Africa4%
🇬🇧 United Kingdom2.5%
🇦🇷 Argentina2.2%
🇮🇪 Ireland2%
Top 5 of 11 shown
Web traffic by country
16K monthly visits
across markets
🇺🇸 United States50%
🇬🇧 United Kingdom13.1%
🇦🇺 Australia13.1%
🇯🇵 Japan10%
🇮🇳 India6.9%
Top 5 markets shown

Patents

Estimated portfolio value
$52M

104 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Paragon 28 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Paragon 28 on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.